Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DRRX

DURECT (DRRX) Stock Price, News & Analysis

DURECT logo

About DURECT Stock (NASDAQ:DRRX)

Key Stats

Today's Range
$1.91
$1.91
50-Day Range
$1.85
$1.96
52-Week Range
$0.48
$2.64
Volume
N/A
Average Volume
699,433 shs
Market Capitalization
$59.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DURECT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

DRRX MarketRank™: 

DURECT scored higher than 22% of companies evaluated by MarketBeat, and ranked 851st out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for DURECT are expected to decrease in the coming year, from ($0.50) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DURECT is -19.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DURECT is -19.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DURECT has a P/B Ratio of 6.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about DURECT's valuation and earnings.
  • Percentage of Shares Shorted

    1.27% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 19.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    DURECT does not currently pay a dividend.

  • Dividend Growth

    DURECT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.27% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DURECT has recently decreased by 19.51%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, DURECT insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.20% of the stock of DURECT is held by insiders.

    • Percentage Held by Institutions

      Only 28.03% of the stock of DURECT is held by institutions.

    • Read more about DURECT's insider trading history.
    Receive DRRX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for DURECT and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    DRRX Stock News Headlines

    Durect Merges with Bausch Health, Delists from Nasdaq
    The End of Elon Musk…?
    While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the verge of its biggest breakthrough yet — a revolutionary form of “Manifested AI” that Forbes has called a multi-trillion-dollar opportunity, potentially sparking a 25,000% growth market and setting up what he believes could be the greatest corporate comeback in history.tc pixel
    See More Headlines

    DRRX Stock Analysis - Frequently Asked Questions

    DURECT Corporation (NASDAQ:DRRX) announced its quarterly earnings data on Tuesday, August, 12th. The specialty pharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.06. The specialty pharmaceutical company earned $0.45 million during the quarter, compared to analysts' expectations of $0.32 million. DURECT had a negative trailing twelve-month return on equity of 259.16% and a negative net margin of 96.19%.

    DURECT shares reverse split on Tuesday, December 6th 2022.The 1-10 reverse split was announced on Tuesday, December 6th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Based on aggregate information from My MarketBeat watchlists, some other companies that DURECT investors own include CymaBay Therapeutics (CBAY), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), GE Aerospace (GE), Catalyst Pharmaceuticals (CPRX) and Pfizer (PFE).

    Company Calendar

    Last Earnings
    8/12/2025
    Today
    10/14/2025
    Next Earnings (Estimated)
    11/12/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - DRUGS
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:DRRX
    CIK
    1082038
    Employees
    80
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    ($0.10)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$8.32 million
    Net Margins
    -96.19%
    Pretax Margin
    -416.01%
    Return on Equity
    -259.16%
    Return on Assets
    -71.78%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.98
    Quick Ratio
    0.95

    Sales & Book Value

    Annual Sales
    $1.66 million
    Price / Sales
    35.80
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $0.29 per share
    Price / Book
    6.59

    Miscellaneous

    Outstanding Shares
    31,054,000
    Free Float
    30,060,000
    Market Cap
    $59.31 million
    Optionable
    Optionable
    Beta
    0.92

    Social Links

    A Guide To High-Short-Interest Stocks Cover

    MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:DRRX) was last updated on 10/14/2025 by MarketBeat.com Staff
    From Our Partners